G L Pappagallo - JoVE Visualize

Showing results (1-10 of 23) with videos related to

Pageof 3

Sort By:

European Journal of Cancer & Clinical Oncology|October 1, 1982

Serum lactate dehydrogenase (LDH) as a prognostic index for non-Hodgkin's lymphomaL Endrizzi, M V Fiorentino, L Salvagno, et al.

Oncology|January 1, 1993

The combination of mitomycin, vinblastine and cisplatin is active in the palliation of stage IIIB-IV non-small-cell lung cancerO Vinante, M Bari, R Segati, et al.

Anticancer Research|March 1, 1994

Biochemical parameters for prognostic evaluation in patients with breast cancerM Gion, R Mione, G L Pappagallo, et al.

The Journal of Urology|January 1, 1996

Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvementF Pagano, P Bassi, G L Ferrante, et al.

Tumori|December 31, 1982

Vindesine in the treatment of squamous cell carcinoma (WHO I), adenocarcinoma (WHO III), and large cell carcinoma (WHO IV) of the lungE Ferrazzi, V Zagonel, O Vinante, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicatorM Gion, R Mione, G L Pappagallo, et al.

Oncology|September 6, 2000

Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapyG Marchioro, G Azzarello, F Viviani, et al.

Tumori|August 1, 1982

Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignanciesE Ferrazzi, G L Pappagallo, R Segati, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993

Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapyL Salvagno, M Sorarù, S M Aversa, et al.

Tumori|June 30, 1984

Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinomaE Ferrazzi, G L Pappagallo, O Nicoletto, et al.

Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:

Pageof 3

European Journal of Cancer & Clinical Oncology|October 1, 1982

Serum lactate dehydrogenase (LDH) as a prognostic index for non-Hodgkin's lymphomaL Endrizzi, M V Fiorentino, L Salvagno, et al.

Oncology|January 1, 1993

The combination of mitomycin, vinblastine and cisplatin is active in the palliation of stage IIIB-IV non-small-cell lung cancerO Vinante, M Bari, R Segati, et al.

Anticancer Research|March 1, 1994

Biochemical parameters for prognostic evaluation in patients with breast cancerM Gion, R Mione, G L Pappagallo, et al.

The Journal of Urology|January 1, 1996

Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvementF Pagano, P Bassi, G L Ferrante, et al.

Tumori|December 31, 1982

Vindesine in the treatment of squamous cell carcinoma (WHO I), adenocarcinoma (WHO III), and large cell carcinoma (WHO IV) of the lungE Ferrazzi, V Zagonel, O Vinante, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicatorM Gion, R Mione, G L Pappagallo, et al.

Oncology|September 6, 2000

Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapyG Marchioro, G Azzarello, F Viviani, et al.

Tumori|August 1, 1982

Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignanciesE Ferrazzi, G L Pappagallo, R Segati, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993

Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapyL Salvagno, M Sorarù, S M Aversa, et al.

Tumori|June 30, 1984

Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinomaE Ferrazzi, G L Pappagallo, O Nicoletto, et al.

Pageof 3